Latest Breaking News On - First approved - Page 1 : vimarsana.com

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJames porterAlexandra balcomNuvalent incInfinity pharmaceuticalsProvidence collegeSage therapeutics incExchange commissionGamida cell ltdSuffolk universityDrug administrationHealth care conferenceChief financial officerPatient impactSenior vice president

Nuvalent Inc (NUVL) Issues Pipeline Update

Nuvalent Inc (NUVL) Issues Pipeline Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJames porterAlexandra balcomDrug administrationHealth care conferenceExchange commissionGamida cell ltdSuffolk universitySage therapeutics incProvidence collegeNuvalent incInfinity pharmaceuticalsChief financial officerPatient impactSenior vice presidentHuman resources

Form 10-K Nuvalent, Inc For: Dec 31

Form 10-K Nuvalent, Inc For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDuke universityNorth carolinaNew hampshireUnited kingdomBoston collegeCredit onCollege of the holy crossNew jerseyDana farber cancer instituteUniversity of massachusettsNew mexicoState of delawareHarvard universityNorthern irelandNorth dakota

NECTIN-4 Offers Attractive Target in Urothelial Cancer and Beyond

As the treatment paradigm in urothelial cancer expands to include agents directed at various targets, NECTIN-4 has emerged as a promising treatment target.

United statesElisabethi heathAstellas pharmaKarmanos cancer instituteWayne state university in detroitWayne state universityVedotin breaks groundFirst approvedHorizon forCancer managUrothelial cancerNectin 4Wayne state universityBriani riniVanderbilt ingram cancer centerVanderbilt university

Nuvalent Announces OnTarget 2026 Operating Plan and Key Anticipated Milestones

Targeting first approved product in 2026 towards realizing mission of bringing new, potential best-in-class treatments to patients with cancer

United kingdomSan franciscoUnited statesAlexandra balcomJames porterPrnewswire nuvalent incExchange commissionNuvalent incHealthcare conferenceChief executive officerNew drug applicationChief financial officerGlobal registrationalFirst pivotalFirst approvedSend cash